以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 截至2025年12月30日收盘，太龙药业（600222）报收于6.66元，较前一交易日上涨1.52%，最新总市值 为38.22亿元。该股当日开盘6.55元，最高6.77元，最低6.5元，成交额达1.55亿元，换手率为4.08%。 《太龙药业关于使用闲置自有资金委托理财的公告》 近日，太龙药业发布关于使用闲置自有资金委托理财的公告。公告显示，公司于2025年12月30日召开第 十届董事会第六次会议，审议通过使用不超过2.5亿元闲置自有资金进行委托理财，投资于已上市金融 机构提供的安全性高、流动性好、单笔期限不超过6个月的低风险理财产品，包括银行理财、货币基 金、国债逆回购等。理财期限为董事会审议通过之日起12个月内，额度内资金可滚动使用。该事项无需 提交股东大会审议。公司已制定相关风控措施，确保资金安全，不影响主营业务正常开展。相关理财资 产计入交易性金融资产，收益计入投资收益或公允价值变动收益。 最新公告列表 ...

Core Viewpoint - Jiangsu Guotai plans to invest no more than 1.83 billion yuan in securities, raising investor concerns about the lack of share buybacks and the timing of the investment plan [2][4][9]. Group 1: Securities Investment Plan - Jiangsu Guotai announced a plan to use idle funds of up to 1.83 billion yuan for securities investment, including new stock subscriptions, stock repurchases, and bond investments [9][14]. - The last time Jiangsu Guotai executed a share buyback was in May 2019, leading to questions from investors regarding the current investment strategy [4][8]. - As of August 22, the company's stock price was 7.60 yuan per share, with a total market capitalization of 12.37 billion yuan [6]. Group 2: Financial Performance - In the first half of 2025, Jiangsu Guotai reported a net profit attributable to shareholders of 545 million yuan, a year-on-year increase of 10.85%, while the net profit after deducting non-recurring gains was 524 million yuan, up 2.05% [25][26]. - The company's operating revenue for the current period was approximately 18.60 billion yuan, reflecting a growth of 5.48% compared to the previous year [26]. Group 3: Wealth Management Plans - Jiangsu Guotai and its subsidiaries plan to use idle funds of up to 12 billion yuan for entrusted wealth management, with a rolling usage period of 12 months from the date of shareholder approval [19][22]. - This marks the second time in 2024 that Jiangsu Guotai has announced a wealth management plan exceeding 10 billion yuan, with the previous plan approved in August 2024 for 11.5 billion yuan [22]. - The wealth management funds will be allocated to low-risk financial products, including structured deposits and government bond reverse repos, to enhance fund utilization efficiency [22].

Group 1 - The company announced that its board approved the use of idle self-owned funds for entrusted wealth management up to 12 billion yuan, focusing on low-risk financial products with high liquidity [1] - The funds can be rolled over within a 12-month period from the date of shareholder meeting approval, ensuring that daily operational needs and fund safety are prioritized [1] - The company aims to enhance fund utilization efficiency and overall performance, ultimately benefiting shareholders through increased investment returns [1] Group 2 - The company announced the termination of the investment in a 400,000-ton lithium-ion battery electrolyte project due to external conditions and industry environment changes, with no significant adverse impact on normal operations or current profits [2] - The company reported a revenue of approximately 18.597 billion yuan for the first half of 2025, representing a year-on-year growth of 5.48%, and a net profit attributable to shareholders of approximately 545 million yuan, reflecting a year-on-year increase of 10.85% [2]

人民财讯8月22日电，江苏国泰（002091）8月22日晚间公告，公司及下属子公司拟使用不超过120亿元 闲置自有资金进行委托理财，用于购买安全性高、流动性好的中低风险理财产品，包括但不限于结构性 存款、收益凭证、大额存单、国债逆回购等。 ...